Clinical Handbook of Psychotropic Drugs for Children and Adolescents
Hogrefe & Huber (Verlag)
978-0-88937-271-9 (ISBN)
- Titel erscheint in neuer Auflage
- Artikel merken
Many psychotropic drugs are prescribed for children and adolescents on the basis of their efficacy in adults, since controlled studies in the corresponding age groups have often not been carried out or reported. Information is, however, available, and has now been brought together in an easy-to-use form, in this child and adolescent version of the "Clinical Handbook of Psychotropic Drugs". Designed to fill a need for a comprehensive but compact and easy-to-use reference, specifically for psychiatrists, psychologists, physicians, nurses and other mental health professionals dealing with children and adolescents, this version summarizes the latest information from the published literature (scientific data, controlled clinical trials and case reports), and clinical experience in compact and easy-to-use charts and bulleted lists for each class of psychotropic drug used in children and adolescents.
Structured similarly to the "Clinical Handbook for Psychotropic Drugs", this version includes, for each class of drugs, both monograph statements on use in children and adolescents and approved indications, as well as the available data concerning off-label indications, findings from open and double-bind studies concerning doses, adverse effects, and other considerations in these age groups.
Introduction; Psychiatric Disorders in Children & Adolescents; Attention Deficit Hyperactivity Disorder (ADHD); Major Depressive Disorder; Bipolar Disorder (BD); Schizophrenia; Anxiety Disorders; Tic Spectrum Disorders; Pervasive Developmental Disorders (PDD); Drugs for Attention Deficit Hyperactivity Disorder (ADHD); Psychostimulants; Comparison of Psychostimulants (chart); Atomoxetine; Clonidine; Augmentation Strategies in ADHD; Antidepressants; Selective Serotonin Reuptake Inhibitors (SSRI); Norepinephrine Dopamine Reuptake Inhibitor (NDRI); Selective Serotonin Norepinephrine Reuptake Inhibitor (SNRI); Serotonin-2 Antagonists/Reuptake Inhibitors (SARI); Noradrenergic/Specific Serotonergic Antidepressants (NaSSA); Nonselective Cyclic Antidepressants; Monoamine Oxidase Inhibitors; Reversible Inhibitor of MAO-A (RIMA); Irreversible Monoamine Oxidase Inhibitors; Antidepressant Doses (chart); Effects of Antidepressants on Neurotransmitters/Receptors (charts); Frequency of Adverse Reactions to Cyclic Antidepressants at Therapeutic Doses (chart); Switching Antidepressants (chart); Antidepressant Augmentation Strategies; Electroconvulsive Treatment (ECT); Antipsychotics (Neuroleptics); "Second-Generation" Antipsychotics (Neuroleptics); ConventionalAntipsychotics (Neuroleptics); Effects of Antipsychotics on Neurotransmitters/Receptors (charts); Frequency (percent)) of Adverse Reactions to Antipsychotics at Therapeutic Doses (chart); Antipsychotic Doses (chart); Comparison of Depot Antipsychotics (chart); Extrapyramidal Side Effects of Antipsychotics (chart); Switching Antipsychotics (chart); Antipsychotic Augmentation Strategies; Agents For Treating Extrapyramidal Side Effects; Comparison of Agents for Treating Extrapyramidal Side Effects (chart); Anxiolytic Agents; Benzodiazepines; Comparison of the Benzodiazepines (chart); Buspirone; Hypnotics/Sedatives; Comparison of Hypnotics/Sedatives (chart); Mood Stabilizers; Lithium; Anticonvulsants; Comparison of Anticonvulsants (chart); Comparison of Adverse Reactions at Therapeutic Doses(chart); Treatment of Substance Abuse Disorders; Disulfiram; Methadone; Other Treatments of Psychiatric Disorders; Adrenergic Agents; Cholinergic Agents; GABA-Agents/Anticonvulsants; Miscellaneous; Herbal and "Natural" Products; Drugs of Abuse; Alcohol; Hallucinogens; Stimulants; Opiates/Narcotics; Inhalants/Aerosols; Gamma Hydroxy Butyrate (GHB); Flunitrazepam (Rohypnol); Glossary; Suggested Readings; Patient and Caregiver Information Sheets; Index of Drugs; Table of Contents.
| Zusatzinfo | tables & charts |
|---|---|
| Verlagsort | Toronto |
| Sprache | englisch |
| Maße | 178 x 254 mm |
| Einbandart | Spiralbindung |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pädiatrie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Psychiatrie / Psychotherapie | |
| ISBN-10 | 0-88937-271-3 / 0889372713 |
| ISBN-13 | 978-0-88937-271-9 / 9780889372719 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
